Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amicus Therapeutics, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FOLD
Nasdaq
8731
https://www.amicusrx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amicus Therapeutics, Inc.
When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?
- Apr 19th, 2024 2:27 pm
Why Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
- Mar 29th, 2024 3:30 pm
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
- Mar 20th, 2024 11:00 am
13 Best Biotech Stocks To Buy Under $20
- Mar 13th, 2024 11:07 am
Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)
- Mar 7th, 2024 4:56 am
Amicus Therapeutics Stock Sees RS Rating Improve To 74
- Mar 5th, 2024 6:50 pm
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
- Mar 2nd, 2024 2:13 pm
Amicus Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
- Mar 1st, 2024 12:14 pm
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
- Mar 1st, 2024 12:00 pm
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 4:25 pm
Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates
- Feb 29th, 2024 4:23 pm
Q4 2023 Amicus Therapeutics Inc Earnings Call
- Feb 29th, 2024 4:49 am
Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates
- Feb 28th, 2024 1:20 pm
Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ...
- Feb 28th, 2024 12:32 pm
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
- Feb 28th, 2024 12:00 pm
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
- Feb 15th, 2024 12:00 pm
Amicus Therapeutics Stock Sees Improved Relative Strength Rating
- Feb 9th, 2024 8:14 pm
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
- Feb 8th, 2024 12:00 pm
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
- Feb 1st, 2024 12:00 pm
Amicus Therapeutics Inc Chief Accounting Officer Sells Company Shares
- Jan 13th, 2024 4:02 am
Scroll